About Eskag Pharma Pvt Ltd
Data last updated:
Eskag Pharma Pvt Ltd is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 February 1977 and has been in existence for over 49 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24234WB1977PTC030897. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹1.8 Cr and a paid-up capital of ₹1.68 Cr. It is led by directors Anil Kumar Agarwal and Sunil Kumar Agarwal.
Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ag – 112 Unit No – 4 8th Flooor Baisakhi Sector – II Saltlake, Kolkata, West Bengal, India – 700091.
As per the financials filed for FY 2025, the company reported a revenue of ₹82.92 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹8.34 Cr (net margin 10.1%) and EBITDA of ₹17.83 Cr (EBITDA margin 21.5%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years.
The company has about 594 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Eskag Sanjeevani and Eskag Pharma. As per MCA filings, the company has open charges of ₹126.84 Cr and satisfied charges of ₹35.15 Cr on record. Court records list 28 cases involving the company, including 17 filed by the company and 10 filed against it; 15 cases are pending. The company has 11 deals on record (7 funding rounds, 4 secondary share transfers), with disclosed funding of ₹10.21 Cr; the latest was in November 2023. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Universal Medicare Private Limited with revenue of ₹77.59 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website eskag.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressAg – 112 Unit No – 4 8th Flooor Baisakhi Sector – II Saltlake, Kolkata, West Bengal, India – 700091
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Eskag Pharma Pvt Ltd
The main business activity of Eskag Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Eskag Pharma Pvt Ltd FY 2025 filings available
Eskag Pharma Pvt Ltd reported revenue of ₹82.92 Cr (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Eskag Pharma Pvt Ltd
Revenue has grown at a compounded annual rate (CAGR) of 7% over three years, including 8% growth in the latest year. EBITDA rose 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Eskag Pharma Pvt Ltd
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹82.92 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹17.83 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹8.34 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Eskag Pharma Pvt Ltd
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 10.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Eskag Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Eskag Pharma Pvt Ltd
Eskag Pharma Pvt Ltd is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Eskag Pharma Pvt Ltd this company | ₹82.92 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Kolkata, West Bengal, India |
| Universal Medicare Private Limited | ₹77.59 Cr (FY 2025) | •••• | •••• | 38.0% | •••• | Mumbai, Maharashtra, India |
| Asence Pharma Private Limited | ₹77.56 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Vadodara, Gujarat, India |
| Vasa Pharma Chem Pvt Ltd | ₹77.38 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Ahmedabad, Gujarat, India |
| Vapi Care Pharma Private Limited | ₹76.81 Cr (FY 2025) | •••• | •••• | -11.0% | •••• | Vapi, Valsad, Gujarat, India |
| Aritex Industries Private Limited | ₹76.79 Cr (FY 2024) | •••• | •••• | 57.0% | •••• | Ludhiana, Punjab, India |
| Mercury Laboratories Limited Listed | ₹76.17 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Mumbai, Maharashtra, India |
| Vovantis Laboratories Private Limited | ₹76.05 Cr (FY 2025) | •••• | •••• | 67.0% | •••• | Vadodara, Gujarat, India |
| Higlance Laboratories Private Limited | ₹75.98 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | New Delhi, Delhi, India |
| Vital Therapeutics and Formulations Private Limited | ₹75.96 Cr (FY 2024) | •••• | •••• | 2.0% | •••• | Hyderabad, Telangana, India |
| Bennet Pharmaceuticals Limited | ₹75.82 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Vadodara, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Eskag Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Eskag Pharma Pvt Ltd
Eskag Pharma Pvt Ltd is audited by MAHENDRA SUBHAS & CO for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MAHENDRA SUBHAS & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Eskag Pharma Pvt Ltd
Eskag Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar Agarwal Also directs: Upashaya Healthcare LLP, Wbcil (Dahej) Limited, West Bengal Chemical Industries Ltd. and 5 more | Director | 11 May 2005 | 21 Years 5 Months | Current |
| Sunil Kumar Agarwal Also directs: Wbcil (Dahej) Limited, West Bengal Chemical Industries Ltd., Bhagirathi Commodities Private Limited and 5 more | Director | 13 Jun 1984 | 42 Years 4 Months | Current |
Ownership and Shareholding of Eskag Pharma Pvt Ltd
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Eskag Pharma Pvt Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jan 2023 | Standard Chartered Bank | ₹15 Cr | Open |
| 28 Jun 2021 | Standard Chartered Bank | ₹17.57 Cr | Open |
| 21 Jan 2020 | Hdfc Bank Limited | ₹77.58 Cr | Open |
| 29 Dec 2018 | Others | ₹44.5 Lakh | Open |
| 02 Feb 2018 | Hdfc Bank Limited | ₹13.4 Cr | Open |
Total charge records: 12 View all charges
Deals & Funding of Eskag Pharma Pvt Ltd
Eskag Pharma Pvt Ltd has 11 deals on record (7 funding rounds, 4 secondary share transfers), with disclosed funding of ₹10.21 Cr; the latest was in November 2023.
Deals on record (5 of 11)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2014 | Funding round | ₹1.4 Cr | Investors: Godavari Dealcom Private Limited |
| Mar 2013 | Funding round | ₹1.82 Cr | Investors: Godavari Dealcom Private Limited , Vipasa Agency Private Limited , Tirupati Metals Pvt Ltd |
| Mar 2012 | Funding round | ₹2.42 Cr | Investors: Vipasa Agency Private Limited |
| May 2010 | Secondary share transfer | Undisclosed | Buyer: Tirupati Metals Pvt Ltd Seller: Dhanterash Dealers Private Limited, Kanhaiya Distributors Private Limited , Panghat Vinimay Private Limited |
| Mar 2010 | Funding round | ₹2 Cr | Investors: Arihant Corporate Consultant Private Limited, Shagun Tie-Up Pvt Ltd , Jay Raj Commodities Pvt Ltd |
Full deal history
All 11 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Eskag Pharma Pvt Ltd
Eskag Pharma Pvt Ltd has 28 court cases on record: 17 filed by Eskag Pharma, 10 filed against it, 1 where it is another party. 15 cases are pending and 13 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 13 | 3 | 5 |
| District courts | 12 | 5 | 8 |
| NCLAT | 3 | 2 | 2 |
Cases on record (5 of 28)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Civil suit | Filed against the company by Next Radio Limited | Pending |
| District court, New Delhi, Delhi | Civil suit | Filed against the company by HT Media Limited | Pending |
| NCLAT, New Delhi | Company appeal | Filed by the company against Vipasa Agency Private Limited and 18 others | Disposed |
| District court, North Twenty Four Parganas, West Bengal | Criminal complaint | Filed by the company against Leisha Pharma Solutions Private Limited | Disposed |
| Allahabad High Court | Court case (ARCO) | Filed against the company by Avadh Pharma Private Limited | Disposed |
Full case history
All 28 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Eskag Pharma Pvt Ltd
Eskag Pharma operates two associated brands: Eskag Sanjeevani and Eskag Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Operates as a standalone multi-speciality hospital offering comprehensive medical care. | eskagsanjeevani.com | |
| Manufactures and supplies pharmaceutical products for therapeutic areas like dermatology and gastroenterology. | eskag.in |
Employees and EPFO Compliance at Eskag Pharma Pvt Ltd
Eskag Pharma Pvt Ltd has a workforce of 594 employees as of Oct 09, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Eskag Pharma Pvt Ltd
Eskag Pharma Pvt Ltd has 3 board changes on record since 1984: 2 appointments and 1 cessation. The latest: Sushil Kumar Agarwal ceased to be Director on 21 Jun 2014.
18 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Eskag Pharma Pvt Ltd
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Eskag Pharma Pvt Ltd
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Eskag Pharma Pvt Ltd
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Eskag Pharma Pvt Ltd
Eskag Pharma has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Eskag Pharma Pvt Ltd
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eskag Pharma Pvt Ltd
Eskag Pharma is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 February 1977 (49+ years old) and is registered under CIN U24234WB1977PTC030897.
Eskag Pharma reported revenue of ₹82.92 Cr for FY 2025 (up 8% YoY).
Eskag Pharma has 2 current directors:
- Anil Kumar Agarwal - Director
- Sunil Kumar Agarwal - Director
Eskag Pharma reported a net profit of ₹8.34 Cr (net margin 10.1%) and EBITDA of ₹17.83 Cr (EBITDA margin 21.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Eskag Pharma is 7% over three years. In the latest year (FY 2025) revenue rose 8%. CAGR is the steady yearly rate that links the first and the last year.
No. Eskag Pharma has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Eskag Pharma is U24234WB1977PTC030897. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eskag Pharma has 28 court cases on record: 17 filed by the company and 10 filed against it. 15 are pending. Most are in the high courts.
Eskag Pharma was incorporated on 24 February 1977, making it 49+ years old. It is registered with the Registrar of Companies, Kolkata.
Eskag Pharma has 11 deals on record (7 funding rounds, 4 secondary share transfers), with disclosed funding of ₹10.21 Cr; the latest was in November 2023.
The peers of Eskag Pharma by revenue are Universal Medicare Private Limited, Asence Pharma Private Limited, Vasa Pharma Chem Pvt Ltd, Vapi Care Pharma Private Limited, Aritex Industries Private Limited and 5 more, all in the Pharma industry (Formulations).